42 Providing temporary use of on-line, non-downloadable machine learning-based, knowledge automation analytics software; Platform as a service (PAAS) featuring computer software platforms for providing a machine learning-based, knowledge automation analytics; Platform as a service (PAAS) featuring computer software platforms for providing a machine learning-based, knowledge automation analytics in the fields of life sciences and healthcare; Providing temporary use of on-line, non-downloadable software for integrating research and diagnostics across data sources in the field of medicine; Providing temporary use of on-line, non-downloadable software for generating structured corpora; Providing temporary use of on-line, non-downloadable software for generating structured corpora in the fields of life sciences and healthcare; Providing temporary use of on-line, non-downloadable software for designing and deploying workflows; Providing temporary use of on-line, non-downloadable software for designing and deploying workflows in the fields of life sciences and healthcare; Providing temporary use of on-line, non-downloadable software for searching on line for biomedical entities and contacting found entities; Providing temporary use of on-line, non-downloadable software for variant analysis and reporting in the field of bioinformatics; Providing temporary use of on-line, non-downloadable bioinformatics software for variant analysis and reporting in the fields of life sciences and healthcare; Providing temporary use of on-line, non-downloadable software for converting disparate unstructured data into a structured form; Providing temporary use of on-line, non-downloadable software for mapping custom variant curation schemas to data found in large corpora; Providing temporary use of on-line, non-downloadable software for generating visualizations of datasets; Providing temporary use of online, non-downloadable software for generating visualizations of datasets in the fields of life sciences and healthcare; Providing temporary use of on-line, non-downloadable software for identifying novel genetic variants and genotype-phenotype relationships, and providing relevancy scores; Providing temporary use of on-line, non-downloadable software for developing personal treatment strategies for patients with diagnosed cancer, patients with hereditary diseases, patients with pre-disposition to a possible genetic disorder, patients with neurological diseases such as Alzheimer's or Dementia, patients with cardiac diseases, and patients with diseases for treatment by microbiome based therapeutic treatments; Providing temporary use of on-line, non-downloadable software for developing personal treatment strategies using patient demographics, clinical data, and genetic factors including drug metabolism, drug response, and drug toxicity for patients with diagnosed cancer, patients with hereditary diseases, patients with pre-disposition to a possible genetic disorder, patients with neurological diseases such as Alzheimer's or Dementia, patients with cardiac diseases, and patients with diseases for treatment by microbiome based therapeutic treatments